Form 8-K - Current report:
SEC Accession No. 0001193125-09-041200
Filing Date
2009-02-27
Accepted
2009-02-27 17:16:16
Documents
3
Period of Report
2009-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 24227
2 PRESS RELEASE OF ARCA BIOPHARMA, INC. DATED FEBRUARY 25 2009 dex991.htm EX-99.1 8874
3 GRAPHIC g48832g14c84.jpg GRAPHIC 3446
  Complete submission text file 0001193125-09-041200.txt   39825
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 09644242
SIC: 2835 In Vitro & In Vivo Diagnostic Substances